Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism

Cell Reports

Volumn 13, Issue 3, 2015, Pages 516-523

  Hammer, Matthieu ^a   Krueger Burg, Dilja ^a   Tuffy, Liam Patrick ^a   Cooper, Benjamin Hillman ^a   Taschenberger, Holger ^a   Goswami, Sarit Pati ^b   Ehrenreich, Hannelore ^a   Jonas, Peter ^b   Varoqueaux, Frederique ^a,c   Rhee, Jeong Seop ^a   Brose, Nils ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLIGIN; NEUROLIGIN 4; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; NERVE CELL ADHESION MOLECULE; NLGN4 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; GABAERGIC TRANSMISSION; GAMMA OSCILLATION; GENE DELETION; HIPPOCAMPAL CA3 REGION; KNOCKOUT MOUSE; LOSS OF FUNCTION MUTATION; MALE; MOUSE; MOUSE MODEL; NERVE CELL NETWORK; NERVOUS SYSTEM PARAMETERS; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; STRATUM PYRAMIDALE; SYNAPTIC INHIBITION; ANIMAL; C57BL MOUSE; CYTOLOGY; GAMMA RHYTHM; GENETICS; GROWTH, DEVELOPMENT AND AGING; INHIBITORY POSTSYNAPTIC POTENTIAL; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTISTIC DISORDER; CA3 REGION, HIPPOCAMPAL; CELL ADHESION MOLECULES, NEURONAL; GABAERGIC NEURONS; GAMMA RHYTHM; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, INBRED C57BL;

EID: 84944677433     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.09.011     Document Type: Article

References (48)

1. Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 2007, 8:45-56.
2. Bemben M.A., Nguyen Q.-A., Wang T., Li Y., Nicoll R.A., Roche K.W. Autism-associated mutation inhibits protein kinase C-mediated neuroligin-4X enhancement of excitatory synapses. Proc. Natl. Acad. Sci. USA 2015, 112:2551-2556.
3. Bolliger M.F., Pei J., Maxeiner S., Boucard A.A., Grishin N.V., Südhof T.C. Unusually rapid evolution of Neuroligin-4 in mice. Proc. Natl. Acad. Sci. USA 2008, 105:6421-6426.
4. Braat S., Kooy R.F. The GABAA receptor as a therapeutic target for neurodevelopmental disorders. Neuron 2015, 86:1119-1130.
5. Bragin A., Jandó G., Nádasdy Z., Hetke J., Wise K., Buzsáki G. Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat. J. Neurosci. 1995, 15:47-60.
6. Cardin J.A., Carlén M., Meletis K., Knoblich U., Zhang F., Deisseroth K., Tsai L.-H., Moore C.I. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 2009, 459:663-667.
7. Cellot G., Cherubini E. GABAergic signaling as therapeutic target for autism spectrum disorders. Front Pediatr. 2014, 2:70.
8. Chanda S., Aoto J., Lee S.J., Wernig M., Südhof T.C. Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking. Mol. Psychiatry 2015.
9. Chao H.-T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.-C., Heintz N., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
10. Chen J.A., Peñagarikano O., Belgard T.G., Swarup V., Geschwind D.H. The emerging picture of autism spectrum disorder: genetics and pathology. Annu. Rev. Pathol. 2015, 10:111-144.
11. Chih B., Engelman H., Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 2005, 307:1324-1328.
12. Delattre V., La Mendola D., Meystre J., Markram H., Markram K. Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. Sci. Rep. 2013, 3:2897.
13. El-Kordi A., Winkler D., Hammerschmidt K., Kästner A., Krueger D., Ronnenberg A., Ritter C., Jatho J., Radyushkin K., Bourgeron T., et al. Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav. Brain Res. 2013, 251:41-49.
14. Fisahn A., Contractor A., Traub R.D., Buhl E.H., Heinemann S.F., McBain C.J. Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations. J. Neurosci. 2004, 24:9658-9668.
15. Fuchs E.C., Zivkovic A.R., Cunningham M.O., Middleton S., Lebeau F.E.N., Bannerman D.M., Rozov A., Whittington M.A., Traub R.D., Rawlins J.N., Monyer H. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 2007, 53:591-604.
16. Gogolla N., Leblanc J.J., Quast K.B., Südhof T.C., Fagiolini M., Hensch T.K. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 2009, 1:172-181.
17. Goswami S.P., Bucurenciu I., Jonas P. Miniature IPSCs in hippocampal granule cells are triggered by voltage-gated Ca2+ channels via microdomain coupling. J. Neurosci. 2012, 32:14294-14304.
18. Hoon M., Soykan T., Falkenburger B., Hammer M., Patrizi A., Schmidt K.F., Sassoè-Pognetto M., Löwel S., Moser T., Taschenberger H., et al. Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. Proc. Natl. Acad. Sci. USA 2011, 108:3053-3058.
19. Jamain S., Quach H., Betancur C., Råstam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29. Paris Autism Research International Sibpair Study.
20. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., Ramanantsoa N., Gallego J., Ronnenberg A., Winter D., et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. USA 2008, 105:1710-1715.
21. Jedlicka P., Hoon M., Papadopoulos T., Vlachos A., Winkels R., Poulopoulos A., Betz H., Deller T., Brose N., Varoqueaux F., Schwarzacher S.W. Increased dentate gyrus excitability in neuroligin-2-deficient mice in vivo. Cereb. Cortex 2011, 21:357-367.
22. Ju A., Hammerschmidt K., Tantra M., Krueger D., Brose N., Ehrenreich H. Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism. Behav. Brain Res. 2014, 270:159-164.
23. Katona L., Lapray D., Viney T.J., Oulhaj A., Borhegyi Z., Micklem B.R., Klausberger T., Somogyi P. Sleep and movement differentiates actions of two types of somatostatin-expressing GABAergic interneuron in rat hippocampus. Neuron 2014, 82:872-886.
24. Kerti-Szigeti K., Nusser Z., Eyre M.D. Synaptic GABAA receptor clustering without the γ2 subunit. J. Neurosci. 2014, 34:10219-10233.
25. Kleijer K.T., Schmeisser M.J., Krueger D.D., Boeckers T.M., Scheiffele P., Bourgeron T., Brose N., Burbach J.P. Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl.) 2014, 231:1037-1062.
26. Krueger D.D., Tuffy L.P., Papadopoulos T., Brose N. The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr. Opin. Neurobiol. 2012, 22:412-422.
27. Lapray D., Lasztoczi B., Lagler M., Viney T.J., Katona L., Valenti O., Hartwich K., Borhegyi Z., Somogyi P., Klausberger T. Behavior-dependent specialization of identified hippocampal interneurons. Nat. Neurosci. 2012, 15:1265-1271.
28. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.-P., Raynaud M., Ronce N., Lemonnier E., Calvas P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557.
29. Mann E.O., Paulsen O. Role of GABAergic inhibition in hippocampal network oscillations. Trends Neurosci. 2007, 30:343-349.
30. Maxwell C.R., Villalobos M.E., Schultz R.T., Herpertz-Dahlmann B., Konrad K., Kohls G. Atypical laterality of resting gamma oscillations in autism spectrum disorders. J. Autism Dev. Disord. 2015, 45:292-297.
31. Möhler H. The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Adv. Pharmacol. 2015, 72:1-36.
32. Pfeffer C.K., Xue M., He M., Huang Z.J., Scanziani M. Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons. Nat. Neurosci. 2013, 16:1068-1076.
33. Poulopoulos A., Aramuni G., Meyer G., Soykan T., Hoon M., Papadopoulos T., Zhang M., Paarmann I., Fuchs C., Harvey K., et al. Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron 2009, 63:628-642.
34. Poulopoulos A., Soykan T., Tuffy L.P., Hammer M., Varoqueaux F., Brose N. Homodimerization and isoform-specific heterodimerization of neuroligins. Biochem. J. 2012, 446:321-330.
35. Rothwell P.E., Fuccillo M.V., Maxeiner S., Hayton S.J., Gokce O., Lim B.K., Fowler S.C., Malenka R.C., Südhof T.C. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014, 158:198-212.
36. Rubenstein J.L.R., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2:255-267.
37. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
38. Soykan T., Schneeberger D., Tria G., Buechner C., Bader N., Svergun D., Tessmer I., Poulopoulos A., Papadopoulos T., Varoqueaux F., et al. A conformational switch in collybistin determines the differentiation of inhibitory postsynapses. EMBO J. 2014, 33:2113-2133.
39. Südhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
40. Takács V.T., Szonyi A., Freund T.F., Nyiri G., Gulyás A.I. Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus. Brain Struct. Funct. 2015, 220:919-940.
41. Tyzio R., Nardou R., Ferrari D.C., Tsintsadze T., Shahrokhi A., Eftekhari S., Khalilov I., Tsintsadze V., Brouchoud C., Chazal G., et al. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014, 343:675-679.
42. Uhlhaas P.J., Singer W. Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks. Neuron 2012, 75:963-980.
43. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., Zhang W., Südhof T.C., Brose N. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
44. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
45. Wolff S.B., Gründemann J., Tovote P., Krabbe S., Jacobson G.A., Müller C., Herry C., Ehrlich I., Friedrich R.W., Letzkus J.J., Lüthi A. Amygdala interneuron subtypes control fear learning through disinhibition. Nature 2014, 509:453-458.
46. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
47. Zhang C., Milunsky J.M., Newton S., Ko J., Zhao G., Maher T.A., Tager-Flusberg H., Bolliger M.F., Carter A.S., Boucard A.A., et al. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J. Neurosci. 2009, 29:10843-10854.
48. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 2003, 302:826-830.